229 related articles for article (PubMed ID: 20667564)
1. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
[TBL] [Abstract][Full Text] [Related]
2. Surgical management of sporadic medullary thyroid cancer.
Noullet S; Trésallet C; Godiris-Petit G; Hoang C; Leenhardt L; Menegaux F
J Visc Surg; 2011 Sep; 148(4):e244-9. PubMed ID: 21885365
[TBL] [Abstract][Full Text] [Related]
3. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
[TBL] [Abstract][Full Text] [Related]
4. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
Mirallié E; Iacobone M; Sebag F; Henry JF
Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
[TBL] [Abstract][Full Text] [Related]
5. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
[TBL] [Abstract][Full Text] [Related]
6. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
7. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis.
Machens A; Gimm O; Ukkat J; Hinze R; Schneyer U; Dralle H
Cancer; 2000 Apr; 88(8):1909-15. PubMed ID: 10760769
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract][Full Text] [Related]
9. Need for a revised staging consensus in medullary thyroid carcinoma.
Boostrom SY; Grant CS; Thompson GB; Farley DR; Richards ML; Hoskin TL; Hay ID
Arch Surg; 2009 Jul; 144(7):663-9. PubMed ID: 19620547
[TBL] [Abstract][Full Text] [Related]
10. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
11. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
12. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors of survival in medullary cancers of the thyroid. Apropos of 51 cases. Clinical, biochemical and immunocytochemical study].
Goudet P; Rogissart F; Petit JM; Vaillant G; Durnerin I; Fraisse J; Justrabo E; Verges B; Cougard P
Ann Chir; 1996; 50(1):23-9. PubMed ID: 8734273
[TBL] [Abstract][Full Text] [Related]
14. Long term prognosis of medullary thyroid carcinoma in 39 patients.
Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.
Scopsi L; Sampietro G; Boracchi P; Del Bo R; Gullo M; Placucci M; Pilotti S
Cancer; 1996 Nov; 78(10):2173-83. PubMed ID: 8918412
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
17. Determinants of life expectancy in medullary thyroid cancer: age does not matter.
de Groot JW; Plukker JT; Wolffenbuttel BH; Wiggers T; Sluiter WJ; Links TP
Clin Endocrinol (Oxf); 2006 Dec; 65(6):729-36. PubMed ID: 17121523
[TBL] [Abstract][Full Text] [Related]
18. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
Papapetrou PD; Polymeris A
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]